Mutations Defining Patient Cohorts With Elevated PD-L1 Expression in Gastric Cancer

Frontiers in Pharmacology - Switzerland
doi 10.3389/fphar.2018.01522
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Frontiers Media SA

Related search

PD-L1 Expression in Lung Cancer and Its Correlation With Driver Mutations: A Meta-Analysis

Scientific Reports
Multidisciplinary
2017English

PD-L1 Expression in Triple-Negative Breast Cancer

Cancer immunology research
Cancer ResearchImmunology
2014English

PD-L1 Gene Expression in Japanese Lung Cancer Patients

Biomedical Reports
GeneticsPharmacologyMolecular BiologyBiochemistryNeuroscienceMedicineToxicologyPharmaceutics
2012English

P3.04-13 PD-L1-Gene Expression by nCounter Correlates With PD-L1 Protein Expression in Advanced Non-Small Cell Lung Cancer (NSCLC)

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

PD-L1 Expression Combined With Microsatellite Instability/Cd8+ Tumor Infiltrating Lymphocytes as a Useful Prognostic Biomarker in Gastric Cancer

Scientific Reports
Multidisciplinary
2019English

Clinicopathological Features of 22C3 PD-L1 Expression With Mismatch Repair, Epstein–Barr Virus Status, and Cancer Genome Alterations in Metastatic Gastric Cancer

Gastric Cancer
Cancer ResearchMedicineOncologyGastroenterology
2018English

EBV-associated Gastric Cancer Evades T-Cell Immunity by PD-1/PD-L1 Interactions

Gastric Cancer
Cancer ResearchMedicineOncologyGastroenterology
2018English

P3.17-01 PD-L1 Expression, EGFR Mutations and ALK Expression in Non-Small Cell Lung Cancer (NSCLC) Patients From Brazil

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Progress in Radiotherapy and Expression of PD-L1 in Esophageal Cancer

Hematology and Medical Oncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy